Large particle focus Target Union Biometrica for expansion of high-end flow cytometry capabilities focused on 3D biology and large or delicate samples, positioning as a bridge between conventional flow cytometry and single-cell platforms to offer improved reproducibility and throughput.

Automation potential Promote value in automating workflows that are currently manual, slow, or variable by integrating Union Biometrica’s automated imaging and sorting platform with existing laboratory information systems and sample pipelines.

3D biology leadership Leverage Union Biometrica’s niche in organoids, spheroids, embryo models, and large models to propose collaborations or pilot programs that expand market reach into emerging NAM-aligned research areas and translational studies.

Revenue signals With reported revenue in a mid single to lower double-digit millions and a small-to-mid sized team, there is an opportunity to upsell higher-value modules, service contracts, or packaged workflows to broaden lifetime value per account.

Strategic partnerships Position as a technology enabler for large biotechs and contract research organizations that rely on high-throughput, reproducible large-particle analysis, aligning with potential customers like well-funded competitors and peers in the life sciences tools space.